Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in improved quality of life but also costs more than another often-used less invasive technique, Christiana Care Health System researchers reported in January in the Journal of the American College of Cardiology.

A researcher in the University of the Basque Country’s (UPV/EHU) Department of Communications Engineering has developed the Ladon security protocol, an efficient mechanism to authenticate, authorize and establish the end-to-end keys (keys for communication between the terminal used by the doctor and the patient's device) for ICDs.

Stem Cell Therapy, Congenital heart, clinical trial/study

Researchers at Okayama University and Okayama University Hospital show that children suffering from a condition known as hypoplastic left heart syndrome experienced some improvement in cardiac function in the months following injection of cardiosphere-derived cells (CDCs).

Healthcare Supply Chain Association (HSCA) President Curtis Rooney released a statement on the annual Budget and Economic Outlook compiled by the Congressional Budget Office (CBO).

AliveCor Inc. announced it has received CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF). The latest version of the AliveECG app for users in the United Kingdom and Ireland now provides patients with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.

The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test may help doctors to detect twice as many myocardial infarctions (MI) in women. Results showed that Abbott’s test was able to diagnose MI in 22 percent of cases for women compared to a standard of 11 percent, when using a sex-specific threshold.

In his lecture, Harrington will argue that simplification of larger trials, better early-phase investigations and the use of electronic health records can ease the path to new research.

Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for BioMimics 3D, a nitinol stent with three-dimensional helical geometry designed for use in the superficial femoral artery.  

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now